Global Immunoassay Analyzers Market Focusing on Trends and Innovations during the Period Until 2027: Thermo Fisher Scientific Inc., bioMérieux SA, Abbott Laboratories, Becton, F. Hoffmann-La Roche Ltd
Research Reports
Apr 13, 2022
Immunoassay Analyzers Market Overview:
An immunoassay is a biochemical test that measures the presence or concentration of analytes or antibodies. Immunoassays have been widely used in many important areas of pharmaceutical analysis such as diagnosis of diseases, therapeutic drug monitoring, clinical pharmacokinetic and bioequivalence studies in drug discovery and pharmaceutical industries. The importance and widespread of immunoassay methods in pharmaceutical analysis are attributed to their inherent specificity, high-throughput, and high sensitivity for the analysis of wide range of analytes in biological samples.
During early stages of drug discovery and development, especially in the clinical pharmacokinetic studies for the new drug candidate, large number of samples are screened. This can be attained by using an analytical method of high throughput or immunoassays. The Immunoassay Analyzers Market has been gaining traction as novel techniques have been developed that can facilitate rapid production of specific antibodies leading to substantial shortening of the time needed for immunoassay methods development. Relatively low cost of the instruments and the reagents have brought potential advantages to immunoassay market and increased the utilization of immunoassay used in pharmaceutical analysis.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1200
Immunoassay Analyzers Market Top Companies:
Thermo Fisher Scientific Inc., bioMérieux SA, Abbott Laboratories, Becton, F. Hoffmann-La Roche Ltd, Dickinson and Company, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Merck KGaA, Quidel Corporation, and DiaSorin S.p.A.
Immunoassay Analyzers Market Segmental Analysis:
The immunoassay market has been segmented into product, indication, technology and end user.
On the basis of product, immunoassay market segmentation includes reagents and kits, software, analyzers/instruments, and services. In 2018, reagents and kits segment turned out to be the largest value contributor to the market due to growing use of reagents and kits in assessment of disorders, rising incidence of chronic and infectious diseases and repetitive purchase by the users.
On the basis of indication, the global immunoassay market is segmented as oncology, endocrinology, cardiology, infectious diseases, therapeutic drug monitoring, autoimmune diseases, and others.
By technology, the immunoassay market has been categorized into enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), chemiluminescence immunoassay (CLIA), enzyme-linked fluorescent assay (ELFA), rapid test, and others.
According to end user, the immunoassay market categorization includes hospitals, blood banks, clinical laboratories, academic and research institutes, pharmaceutical and biotechnology companies, and others.
Immunoassay Analyzers Market Regional Overview:
Geographically, immunoassay market is segmented into the Americas, Europe, Asia Pacific and the Middle East and Africa.
In 2018, the Americas has been evaluated to have held a substantial share in the immunoassay market due to availability of government funds, surging number of research projects in laboratories, presence of major industry players, and rapid adoption of the procedure in clinical diagnostics in the Canada and U.S. Market players such as Thermo Fisher Scientific, Abbott Laboratories, Dickinson and Company, Becton etc. are all headquartered in the U.S. have been adding considerable growth impetus to the immunoassay market in the region.
Europe is expected to hold the second-largest share in the immunoassay market owing to the growing adoption in diagnostic measures, thriving pharmaceutical and biotechnology market in countries like UK, Germany, and France as well as rising use of chemiluminescent immunoassay.
Asia-Pacific immunoassay market is anticipated to register significant growth over the forecast period due to rising prevalence of chronic diseases, expanding geriatric population, increasing healthcare spending and enhanced use of immunoassay tests. The population of 60 years or older in Asia-Pacific by the end of 2050 is expected to reach 1.3 billion. As older people are more prone to suffer from chronic and other disorders, the expansive geriatric population is a potent indicator for the substantial growth of immunoassay market in the region.
Middle East & Africa immunoassay market is expected to witness the modest market growth over 2019-2025. Developing healthcare infrastructure in the Gulf Cooperation Council (GCC) countries such as the United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Bahrain, and Oman would attribute to market growth.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/immunoassay-analyzers-market-1200
Browse Related Reports at:
Life Sciences BPO Market Research Report – Forecast till 2027
Global Molecular Modeling Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact Information:
Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 628 258 0071 Email: sales@marketresearchfuture.com
Tags:
PR-Wirein, Wire, Research Newswire, English